Dry Eye Syndrome Market Analysis

  • Report ID: 4587
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Dry Eye Syndrome Market Segmentation:

End-user Segment Analysis

The global dry eye syndrome market is segmented and analyzed for demand and supply by end user into hospitals, eye clinics, and others. Out of which, the eye clinics segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the higher demand and greater number of eye clinics and optometrists present all around the world. Furthermore, eye clinics have the specialty in providing treatment for the eye disorders, that leads to better facilities and advanced technique adoption for the treatment of the diseases, and it is further expected to boost the segment’s growth in the market. In 2022, the United States have nearly 1000 eye surgery clinics. Moreover, in 123 countries, there are around 300,000 optometrists. Furthermore, according to the World Economic Forum, to meet the global needs, the world needs around 14 million optometrists.

Treatment Segment Analysis

Moreover, the global dry eye syndrome market can be segmented by treatment into nutritional supplements, and surgery. Out of these, the nutritional supplements segment is expected to hold the largest share over the forecast period. This can be attributed to an upsurge in the intake of dietary supplements in the form of vitamin D and vitamin B12 that helps in providing relief from the symptoms such as inflammation and alleviating burning. In addition, mineral oils are also present in the eye drops that treat mild to moderate dry eye disorders, and it is predicted to surge the growth of the segment in the market.

Our in-depth analysis of the global market includes the following segments:

                  By Type

  • Evaporative
  •  Aqueous

                  By Diagnosis

  • Schirmer Test
  • Eye Exam

                  By End User

  • Hospital
  • Eye Clinics
  • Others

                  By Treatment

  • Nutritional Supplement
  • Surgery

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of dry eye syndrome is evaluated at USD 6.75 billion.

The global dry eye syndrome market size was worth around USD 6.4 billion in 2025 and is set to register a CAGR of around 6.1%, exceeding USD 11.57 billion revenue by 2035.

North America dry eye syndrome market will secure around 40.8% share by 2035, driven by a high number of dry eye sufferers and increasing use of eye drops.

Key players in the market include Lumenis Be Ltd., Johnson & Johnson Services Inc., Alcon Vision LLC, Allergan (AbbVie), Novartis AG, Allostera Pharma Inc., I-Med Pharma Inc., Acadia Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos